Works matching IS 01615505 AND DT 2006 AND VI 47 AND IP 6

Results: 34

SPECT Imaging in the Diagnosis of Pulmonary Embolism: Automated Detection of Match and Mismatch Defects by Means of Image-Processing Techniques.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 968

By:

Reinartz, Patrick;
Kaiser, Hans-Juergen;
Wildberger, Joachim E.;
Gordji, Cirus;
Nowak, Bernd;
Buell, Ulrich

Publication type:

Article

SNMTS Offers Grants for NM Practitioner Program: June 15 Deadline for Applicants.

Published in:: Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 33N
Publication type:: Article

Correction.

Published in:: Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 903
Publication type:: Article

Correction.

Published in:: Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 42N
Publication type:: Article

PET as Focus of Annual BMJ Spoof.

Published in:: Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 42N
Publication type:: Article

Brookhaven and Mt. Sinai Join in Translational Research.

Published in:: Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 28N
Publication type:: Article

Impact of Animal Handling on the Results of 18F-FDG PET Studies in Mice.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 999

By:

Fueger, Barbara J.;
Czernin, Johannes;
Hildebrandt, Isabel;
Tran, Chris;
Halpern, Benjamin S.;
Stout, David;
Phelps, Michael E.;
Weber, Wolfgang A.

Publication type:

Article

Intertumoral Differences in Hypoxia Selectivity of the PET Imaging Agent 64Cu(II)-Diacetyl- Bis(N4-Methylthiosemicarbazone).

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 989

By:

Hong Yuan;
Schroeder, Thies;
Bowsher, James E.;
Hedlund, Laurence W.;
Wong, Terence;
Dewhirst, Mark W.

Publication type:

Article

Characterization and Development of a Peptide (p160) with Affinity for Neuroblastoma Cells.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 981

By:

Askoxylakis, Vasileios;
Mier, Walter;
Zitzmann, Sabine;
Ehemann, Volker;
Jianbing Zhang;
Krämer, Susanne;
Beck, Carmen;
Schwab, Manfred;
Eisenhut, Michael;
Haberkorn, Uwe

Publication type:

Article

Noninvasive Measurement of Cardiovascular Function in Mice with High-Temporal-Resolution Small-Animal PET.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 974

By:

Kreissl, Michael C.;
Hsiao-Ming Wu;
Stout, David B.;
Ladno, Waldemar;
Schindler, Thomas H.;
Xiaoli Zhang;
Prior, John O.;
Prins, Mayumi L.;
Chatziioannou, Arion F.;
Sung-Cheng Huang;
Schelbert, Heinrich R.

Publication type:

Article

Role of Nuclear Medicine in the Management of Cutaneous Malignant Melanoma.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 957

By:

Belhocine, Tarik Z.;
Scott, Andrew M.;
Even-Sapir, Einat;
Urbain, Jean-Luc;
Essner, Richard

Publication type:

Article

18F-FDOPA PET Imaging of Brain Tumors: Comparison Study with 18F-FDG PET and Evaluation of Diagnostic Accuracy.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 904

By:

Wei Chen;
Silverman, Daniel H. S.;
Delaloye, Sibylle;
Czernin, Johannes;
Kamdar, Nirav;
Pope, Whitney;
Satyamurthy, Nagichettiar;
Schiepers, Christiaan;
Cloughesy, Timothy

Publication type:

Article

Effects of Pegfilgrastim on Normal Biodistribution of 18F-FDG: Preclinical and Clinical Studies.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 950

By:

Jacene, Heather A.;
Ishimori, Takayoshi;
Engles, James M.;
Leboulleux, Sophie;
Stearns, Vered;
Wahl, Richard L.

Publication type:

Article

Comparison of Image-Derived and Arterial Input Functions for Estimating the Rate of Glucose Metabolism in Therapy-Monitoring 18F-FDG PET Studies.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 945

By:

de Geus-Oei, Lioe-Fee;
Visser, Eric P.;
Krabbe, Paul F. M.;
van Hoorn, Bas A.;
Koenders, Emile B.;
Willemsen, Antoon T.;
Pruim, Jan;
Corstens, Frans H. M.;
Oyen, Wim J. G.

Publication type:

Article

Value of 11C-Choline PET and Contrast-Enhanced CT for Staging of Bladder Cancer: Correlation with Histopathologic Findings.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 938

By:

Picchio, Maria;
Treiber, Uwe;
Beer, Ambros J.;
Metz, Stefan;
Bössner, Patrick;
van Randenborgh, Heiner;
Paul, Roger;
Weirich, Gregor;
Souvatzoglou, Michael;
Hartung, Rudolf;
Schwaiger, Markus;
Piert, Morand

Publication type:

Article

Characterization of the SPECT 5-HT2A Receptor Ligand 123I-R91150 in Healthy Volunteers: Part 2--Ketanserin Displacement.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 929

By:

Catafau, Ana M.;
Danus, Monica;
Bullich, Santiago;
Nucci, Gianluca;
Llop, Jordi;
Abanades, Sergi;
Cunningham, Vincent J.;
Eersels, Jos L. H.;
Pavia, Javier;
Farre, Magi

Publication type:

Article

Characterization of the SPECT 5-HT2A Receptor Ligand 123I-R91150 in Healthy Volunteers: Part 1--Pseudoequilibrium Interval and Quantification Methods.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 919

By:

Catafau, Ana M.;
Danus, Monica;
Bullich, Santiago;
Llop, Jordi;
Perich, Javier;
Cunningham, Vincent J.;
Plaza, Pedro;
Penengo, Maria M.;
Eersels, Jos L. H.;
Squassante, Lisa;
Ros, Domenec;
Barbanoj, Manel

Publication type:

Article

Novel Human IgG2b/Murine Chimeric Antitenascin Monoclonal Antibody Construct Radiolabeled with 131I and Administered into the Surgically Created Resection Cavity of Patients with Malignant Glioma: Phase I Trial Results.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 912

By:

Reardon, David A.;
Quinn, Jennifer A.;
Akabani, Gamal;
Coleman, R. Edward;
Friedman, Allan H.;
Friedman, Henry S.;
Herndon II, James E.;
McLendon, Roger E.;
Pegram, Charles N.;
Provenzale, James M.;
Dowell, Jeannette M.;
Rich, Jeremy N.;
Vredenburgh, James J.;
Desjardins, Annick;
Sampson, John H.;
Gururangan, Sridharan;
Wong, Terence Z.;
Badruddoja, Michael A.;
Xiao-Guang Zhao;
Bigner, Darell D.

Publication type:

Article

18F-FDG PET as a Candidate for "Qualified Biomarker": Functional Assessment of Treatment Response in Oncology.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 901

By:

Larson, Steven M.;
Schwartz, Lawrence H.

Publication type:

Article

Targeted Radiotherapy: Is the "Holy Grail" in Sight?

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 899

By:

Mothersill, Carmel;
Seymour, Colin B.

Publication type:

Article

FROM THE LITERATURE.

Published in:: Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 34N
Publication type:: Article

Charting the Progress of Medical Imaging.

Published in:: Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 33N
Publication type:: Article

First Evaluation of a 99mTc-Tricarbonyl Complex, 99mTc(CO)3(LAN), as a New Renal Radiopharmaceutical in Humans.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 1032

By:

Lipowska, Malgorzata;
Haiyang He;
Malveaux, Eugene;
Xiaolong Xu;
Marzilli, Luigi G.;
Taylor, Andrew

Publication type:

Article

National Oncologic PET Registry Opens.

Published in:: Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 28N
Publication type:: Article

National Oncologic PET Registry Begins Accepting Patient Data.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 27N

By:

Cannon, Hugh

Publication type:

Article

Connecting Our Past With the Future.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 25N

By:

Conti, Peter S.

Publication type:

Article

A Memoir of Pediatric Nuclear Medicine: Part III: Finding a Place for Nuclear Medicine.

Published in:: Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 14N
Publication type:: Article

SNM Annual Meeting Focuses on Molecular Imaging/Nuclear Medicine Research.

Published in:: Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 13N
Publication type:: Article

Consensus Recommendations for the Use of 18F-FDG PET as an Indicator of Therapeutic Response in Patients in National Cancer Institute Trials.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 1059

By:

Shankar, Lalitha K.;
Hoffman, John M.;
Bacharach, Steve;
Graham, Michael M.;
Karp, Joel;
Lammertsma, Adriaan A.;
Larson, Steven;
Mankoff, David A.;
Siegel, Barry A.;
den Abbeele, Annick Van;
Yap, Jeffrey;
Sullivan, Daniel

Publication type:

Article

Log Normal Distribution of Cellular Uptake of Radioactivity: Implications for Biologic Responses to Radiopharmaceuticals.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 1049

By:

Neti, Prasad V. S. V.;
Howell, Roger W.

Publication type:

Article

Synthesis and In Vivo Evaluation of 2 High-Affinity 76Br-Labeled σ2-Receptor Ligands.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 1041

By:

Rowland, Douglas J.;
Zhude Tu;
Jinbin Xu;
Ponde, Datta;
Mach, Robert H.;
Welch, Michael J.

Publication type:

Article

Preclinical Pharmacokinetic, Biodistribution, Toxicology, and Dosimetry Studies of 111In-DTPA-Human Epidermal Growth Factor: An Auger Electron--Emitting Radiotherapeutic Agent for Epidermal Growth Factor Receptor--Positive Breast Cancer.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 1023

By:

Reilly, Raymond M.;
Chen, Paul;
Wang, Judy;
Scollard, Deborah;
Cameron, Ross;
Vallis, Katherine A.

Publication type:

Article

18F-FDG Assessment of Glucose Disposal and Production Rates During Fasting and Insulin Stimulation: A Validation Study.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 1016

By:

Iozzo, Patricia;
Gastaldelli, Amalia;
Järvisalo, Mikko J.;
Kiss, Jan;
Borra, Ronald;
Buzzigoli, Emma;
Viljanen, Antti;
Naum, G.;
Viljanen, Tapio;
Oikonen, Vesa;
Knuuti, Juhani;
Savunen, Timo;
Salvadori, Piero A.;
Ferrannini, Ele;
Nuutila, Pirjo

Publication type:

Article

Radiation-Induced Biologic Bystander Effect Elicited In Vitro by Targeted Radiopharmaceuticals Labeled with α-, β-, and Auger Electron--Emitting Radionuclides.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 1007

By:

Boyd, Marie;
Ross, Susan C.;
Dorrens, Jennifer;
Fullerton, Natasha E.;
Ker Wei Tan;
Zalutsky, Michael R.;
Mairs, Robert J.

Publication type:

Article

Works matching IS 01615505 AND DT 2006 AND VI 47 AND IP 6

SPECT Imaging in the Diagnosis of Pulmonary Embolism: Automated Detection of Match and Mismatch Defects by Means of Image-Processing Techniques.

SNMTS Offers Grants for NM Practitioner Program: June 15 Deadline for Applicants.

Correction.

Correction.

PET as Focus of Annual BMJ Spoof.

Brookhaven and Mt. Sinai Join in Translational Research.

Impact of Animal Handling on the Results of <sup>18</sup>F-FDG PET Studies in Mice.

Intertumoral Differences in Hypoxia Selectivity of the PET Imaging Agent <sup>64</sup>Cu(II)-Diacetyl- Bis(N<sup>4</sup>-Methylthiosemicarbazone).

Characterization and Development of a Peptide (p160) with Affinity for Neuroblastoma Cells.

Noninvasive Measurement of Cardiovascular Function in Mice with High-Temporal-Resolution Small-Animal PET.

Role of Nuclear Medicine in the Management of Cutaneous Malignant Melanoma.

<sup>18</sup>F-FDOPA PET Imaging of Brain Tumors: Comparison Study with <sup>18</sup>F-FDG PET and Evaluation of Diagnostic Accuracy.

Effects of Pegfilgrastim on Normal Biodistribution of <sup>18</sup>F-FDG: Preclinical and Clinical Studies.

Comparison of Image-Derived and Arterial Input Functions for Estimating the Rate of Glucose Metabolism in Therapy-Monitoring <sup>18</sup>F-FDG PET Studies.

Value of <sup>11</sup>C-Choline PET and Contrast-Enhanced CT for Staging of Bladder Cancer: Correlation with Histopathologic Findings.

Characterization of the SPECT 5-HT<sub>2A</sub> Receptor Ligand <sup>123</sup>I-R91150 in Healthy Volunteers: Part 2--Ketanserin Displacement.

Characterization of the SPECT 5-HT<sub>2A</sub> Receptor Ligand <sup>123</sup>I-R91150 in Healthy Volunteers: Part 1--Pseudoequilibrium Interval and Quantification Methods.

Novel Human IgG2b/Murine Chimeric Antitenascin Monoclonal Antibody Construct Radiolabeled with <sup>131</sup>I and Administered into the Surgically Created Resection Cavity of Patients with Malignant Glioma: Phase I Trial Results.

<sup>18</sup>F-FDG PET as a Candidate for "Qualified Biomarker": Functional Assessment of Treatment Response in Oncology.

Targeted Radiotherapy: Is the "Holy Grail" in Sight?

FROM THE LITERATURE.

Charting the Progress of Medical Imaging.

First Evaluation of a <sup>99m</sup>Tc-Tricarbonyl Complex, <sup>99m</sup>Tc(CO)<sub>3</sub>(LAN), as a New Renal Radiopharmaceutical in Humans.

National Oncologic PET Registry Opens.

National Oncologic PET Registry Begins Accepting Patient Data.

Connecting Our Past With the Future.

A Memoir of Pediatric Nuclear Medicine: Part III: Finding a Place for Nuclear Medicine.

SNM Annual Meeting Focuses on Molecular Imaging/Nuclear Medicine Research.

Consensus Recommendations for the Use of <sup>18</sup>F-FDG PET as an Indicator of Therapeutic Response in Patients in National Cancer Institute Trials.

Log Normal Distribution of Cellular Uptake of Radioactivity: Implications for Biologic Responses to Radiopharmaceuticals.

Synthesis and In Vivo Evaluation of 2 High-Affinity <sup>76</sup>Br-Labeled σ<sub>2</sub>-Receptor Ligands.

Preclinical Pharmacokinetic, Biodistribution, Toxicology, and Dosimetry Studies of <sup>111</sup>In-DTPA-Human Epidermal Growth Factor: An Auger Electron--Emitting Radiotherapeutic Agent for Epidermal Growth Factor Receptor--Positive Breast Cancer.

<sup>18</sup>F-FDG Assessment of Glucose Disposal and Production Rates During Fasting and Insulin Stimulation: A Validation Study.

Radiation-Induced Biologic Bystander Effect Elicited In Vitro by Targeted Radiopharmaceuticals Labeled with α-, β-, and Auger Electron--Emitting Radionuclides.